Clinical trial
Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and…
NCT00124930 · Alberta Health services, Other · Terminated
Key facts
| NCT number | NCT00124930 |
|---|---|
| Title | Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer |
| Official title | A Randomized Double-blind, Parallel Group Study Comparing Olanzapine (Zyprexa) With Haloperidol (Novo-peridol) for the Relief of Nausea and Vomiting in Patients With Advanced Cancer |
| Lead sponsor | Alberta Health services, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nausea, Neoplasms |
| Intervention type | Drug |
| Interventions | Olanzapine, Haldol |
| Enrollment | 80 |
| Start date | May 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jul 29, 2005 |
| Last update posted | Jan 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: